Diagnostic performance of fecal eosinophil-derived neurotoxin and lipocalin-2 in pediatric inflammatory bowel disease - Quiz - MDSpire

Evaluating the Diagnostic Efficacy of Fecal Eosinophil-Derived Neurotoxin and Lipocalin-2 in Children with Inflammatory Bowel Disease

  • By

  • Ragaey Ahmad Eid

  • Nada Atteya Fakhry

  • Doaa Mabrouk Ahmed

  • Mahmoud Hodeib

  • July 17, 2026

Share

Original Source(s)

Diagnostic performance of fecal eosinophil-derived neurotoxin and lipocalin-2 in pediatric inflammatory bowel disease

  • by Ragaey Ahmad Eid, Nada Atteya Fakhry, Doaa Mabrouk Ahmed, Mahmoud Hodeib

  • July 17, 2026

Related Content

Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease

Shared inflammatory architecture and therapeutic tensions between psoriasis and Crohn’s disease